Ching Hsu
Impact in
-
- Pain Mechanisms and Treatments
Papers in
- Oncology 7
- Colorectal Cancer Treatments and Studies 4
-
- Protein Degradation and Inhibitors 3
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- Domenico Merante (4 shared papers)Julio Rosenstock (2 shared papers)Uma Sharma (2 shared papers)Hamim Zahir (7 shared papers)Suman Wason (1 shared paper)Stephen A. Cooper (1 shared paper)Roger G. Berlin (1 shared paper)Byron Cryer (1 shared paper)
- Journals
- Blood (3 papers)The Journal of Clinical Pharmacology (2 papers)Journal of Clinical Oncology (1 paper)Pain Research and Management (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Ching Hsu
23 papers receiving 363 citations
Peers
Comparison fields: 5 of 60
- Physiology 125
- Internal Medicine 16
- Hepatology 35
- Neurology 56
- Oncology 84
Countries citing papers authored by Ching Hsu
This map shows the geographic impact of Ching Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching Hsu more than expected).
Fields of papers citing papers by Ching Hsu
This network shows the impact of papers produced by Ching Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching Hsu. The network helps show where Ching Hsu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ching Hsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 81 | |
| 2 | 2016 | 52 | |
| 3 | 2017 | 31 | |
| 4 | 2005 | 30 | |
| 5 | 2019 | 26 | |
| 6 | 2018 | 24 | |
| 7 | 2013 | 22 | |
| 8 | 2018 | 14 | |
| 9 | 2011 | 14 | |
| 10 | 2016 | 13 | |
| 11 | 2018 | 10 | |
| 12 | 2023 | 8 | |
| 13 | 2022 | 8 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2019 | 4 | |
| 18 | 2022 | 4 | |
| 19 | Abstract 12074: A Randomized, Open-Label, Multicenter Study of the Efficacy and Safety of Edoxaban Monotherapy versus Low-Molecular Weight Heparin/Warfarin in Patients With Symptomatic Deep Vein Thrombosis - Edoxaban Thrombus Reduction Imaging Study (eTRIS) | 2014 | 4 |
| 20 | 2021 | 3 |
About Ching Hsu
Ching Hsu is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hematology and Internal Medicine, having authored 23 papers that have together received 369 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Protein Degradation and Inhibitors (3 papers), Pain Mechanisms and Treatments (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Multiple Myeloma Research and Treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Physiology (125 citations), Internal Medicine (16 citations), Hepatology (35 citations), Neurology (56 citations) and Oncology (84 citations). Ching Hsu has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Domenico Merante, Julio Rosenstock, Uma Sharma, Hamim Zahir, Suman Wason, Stephen A. Cooper, Roger G. Berlin, Byron Cryer, David R. Jacobs and Brian Schwartz. Their work appears in journals such as Blood, The Journal of Clinical Pharmacology, Journal of Clinical Oncology, Pain Research and Management and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.